Intensive care medicine in 2050: vasopressors in sepsis.

about

Intensive care medicine in 2050: vasopressors in sepsis.

Item

http://www.wikidata.org/entity/Q50238279

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intensive care medicine in 2050: vasopressors in sepsis.

@en

Intensive care medicine in 2050: vasopressors in sepsis.

@nl

type

Item

label

Intensive care medicine in 2050: vasopressors in sepsis.

@en

Intensive care medicine in 2050: vasopressors in sepsis.

@nl

prefLabel

Intensive care medicine in 2050: vasopressors in sepsis.

@en

Intensive care medicine in 2050: vasopressors in sepsis.

@nl

P1476

Intensive care medicine in 2050: vasopressors in sepsis.

@en

P2093

James A Russell

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Teboul

http://www.w3.org/2001/XMLSchema#string

P2860

Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials

Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.

Vasopressin versus norepinephrine infusion in patients with septic shock.

A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.

Feasibility, Utility, and Safety of Midodrine During Recovery Phase From Septic Shock.

Angiotensin II for the Treatment of Vasodilatory Shock.

Genomics and pharmacogenomics of sepsis: so close and yet so far.

P2888

s00134-017-4909-7

P31

scholarly article

P356

10.1007/S00134-017-4909-7

http://www.w3.org/2001/XMLSchema#string

P50

Jacques Duranteau

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28861671

http://www.w3.org/2001/XMLSchema#string